title: How should FCHL be defined and how should we think about its metabolic bases?
authors.affiliation: Mike Rosenbloom Laboratory for Cardiovascular Research, Room H7.22, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada. allan.sniderman@muhc.mcgill.ca
authors.forename: A D
authors.initials: AD
authors.lastname: Sniderman
authors.forename: J
authors.initials: J
authors.lastname: Ribalta
authors.forename: M
authors.initials: M
authors.lastname: Castro Cabezas
mesh_terms: D015984:Causality; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000235:genetics / Q000378:metabolism*; D008962:Models, Theoretical